Holen Sie sich die Stockscreener-App
1.40
0.00%
0.00
Handel nachbörslich:
1.43
0.03
+2.14%
Schlusskurs vom Vortag:
$1.40
Offen:
$1.42
24-Stunden-Volumen:
43,690
Relative Volume:
0.43
Marktkapitalisierung:
$17.89M
Einnahmen:
$2.47M
Nettoeinkommen (Verlust:
$-13.87M
KGV:
-1.1475
EPS:
-1.22
Netto-Cashflow:
$-12.42M
1W Leistung:
-4.76%
1M Leistung:
-36.01%
6M Leistung:
+2.94%
1J Leistung:
-61.11%
1-Tages-Spanne:
$1.3703
$1.4425
1-Wochen-Bereich:
$1.335
$1.56
52-Wochen-Spanne:
$1.30
$4.98
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Firmenname
Collplant Biotechnologies Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CLGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
1.40 | 17.89M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.36 | 115.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.87 | 81.34B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.65 | 52.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.95 | 51.59B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.04 | 37.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-17 | Eingeleitet | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Aktie (CLGN) Neueste Nachrichten
CollPlant Shareholders Approve All Proposals at December 31, 2025 General Meeting - TipRanks
Can Innovatus Entertainment Networks Limited Overcome Bearish SentimentVWAP Trading Strategies & Fast Profit Capital Growth - bollywoodhelpline.com
Is CollPlant Biotechnologies Ltd a good long term investmentPortfolio Allocation Tips & Free Daily Market Summary and Trend Reports - earlytimes.in
Analysts Apply Wyckoff Model to Betex India Limited StockEarnings Per Share Trends & Receive Monthly Expert Trading Blueprints - bollywoodhelpline.com
How institutional buying supports CollPlant Biotechnologies Ltd. stockTrade Risk Report & Fast Exit and Entry Trade Guides - Улправда
Is CollPlant Biotechnologies Ltd. (CPT) stock a buy during volatile marketsJuly 2025 Market Mood & Fast Entry and Exit Trade Plans - Улправда
How sustainable is CollPlant Biotechnologies Ltd. stock dividend payout2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Will CollPlant Biotechnologies Ltd. stock see PE expansion2025 Market Outlook & Free Technical Pattern Based Buy Signals - DonanımHaber
Can CollPlant Biotechnologies Ltd. stock continue upward trend2025 Investor Takeaways & Fast Gain Swing Alerts - DonanımHaber
How geopolitical risks impact CollPlant Biotechnologies Ltd. (CPT) stockProfit Target & Weekly Return Optimization Alerts - DonanımHaber
Can CollPlant Biotechnologies Ltd. stock deliver surprise earnings beatJuly 2025 Volume & Weekly High Momentum Picks - Улправда
CollPlant shares rise on expanded partnership with STEMCELL Technologies - MSN
What analysts say about CollPlant Biotechnologies Ltd stockMarket Entry Points & Free Stock Predictions and Analysis - earlytimes.in
How CollPlant Biotechnologies Ltd. (CPT) stock trades after earningsWeekly Volume Report & Capital Protection Trading Alerts - Newser
How CollPlant Biotechnologies Ltd. (CPT) stock reacts to monetary easing2025 Geopolitical Influence & Verified Momentum Stock Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock maintain growth trajectory2025 Top Gainers & Technical Confirmation Trade Alerts - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock resilient in recession scenariosWall Street Watch & Daily Stock Trend Watchlist - Newser
Can CollPlant Biotechnologies Ltd. stock hit record highs againWeekly Investment Recap & Weekly High Conviction Ideas - Newser
Is CollPlant Biotechnologies Ltd. (CPT) stock a top pick for value investorsJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Is CollPlant Biotechnologies Ltd. stock a buy in volatile marketsPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Will CollPlant Biotechnologies Ltd. (CPT) stock deliver stable dividends2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
What MACD trends signal for CollPlant Biotechnologies Ltd. (CPT) stockMarket Trend Review & Verified Technical Signals - Newser
CollPlant Biotechnologies Reports Q3 2025 Financial Results - MSN
Is CollPlant Biotechnologies Ltd. overvalued or undervalued? - Markets Mojo
CollPlant Biotechnologies’ (CLGN) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World
D. Boral Capital Maintains CollPlant Biotechnologies (CLGN) Buy Recommendation - Nasdaq
CLGN Analyst Rating Maintained: November 2025 Update | CLGN Stoc - GuruFocus
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31 - Investing.com Nigeria
CollPlant Biotechnologies Announces Annual and Extraordinary General Meeting for December 2025 - TipRanks
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer) | CLGN SEC FilingForm 6-K - Stock Titan
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - marketscreener.com
CollPlant (CLGN) Sees Significant Q3 Revenue Growth and Advances in Bioprinting - GuruFocus
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention - Stocktwits
CollPlant shares edge down as Q3 revenue falls short of estimates - Investing.com Australia
CollPlant shares edge down as Q3 revenue falls short of estimates By Investing.com - Investing.com South Africa
CollPlant Biotechnologies' Q3 revenue rises on rhCollagen sales, cuts workforce - TradingView
CLGN: Revenue and net loss improved year-over-year, with expanded North American operations and new product milestones - TradingView
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PR Newswire
CollPlant Biotechnologies's Earnings Outlook - Sahm
Finanzdaten der Collplant Biotechnologies Ltd-Aktie (CLGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):